These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 15031783)
1. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. Ströher U; DiCaro A; Li Y; Strong JE; Aoki F; Plummer F; Jones SM; Feldmann H J Infect Dis; 2004 Apr; 189(7):1164-7. PubMed ID: 15031783 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Winslow S; Hoopes J; Li JK; Lee J; Carson DA; Cottam HB; Sidwell RW Antiviral Res; 2006 Aug; 71(1):53-63. PubMed ID: 16621037 [TBL] [Abstract][Full Text] [Related]
4. In vitro inhibition of SARS virus replication by human interferons. Dahl H; Linde A; Strannegård O Scand J Infect Dis; 2004; 36(11-12):829-31. PubMed ID: 15764169 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus. Saijo M; Morikawa S; Fukushi S; Mizutani T; Hasegawa H; Nagata N; Iwata N; Kurane I Antiviral Res; 2005 Jun; 66(2-3):159-63. PubMed ID: 15911031 [TBL] [Abstract][Full Text] [Related]
6. Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). Sainz B; Mossel EC; Peters CJ; Garry RF Virology; 2004 Nov; 329(1):11-7. PubMed ID: 15476870 [TBL] [Abstract][Full Text] [Related]
7. Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV. Lokugamage KG; Hage A; de Vries M; Valero-Jimenez AM; Schindewolf C; Dittmann M; Rajsbaum R; Menachery VD J Virol; 2020 Nov; 94(23):. PubMed ID: 32938761 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Chen F; Chan KH; Jiang Y; Kao RY; Lu HT; Fan KW; Cheng VC; Tsui WH; Hung IF; Lee TS; Guan Y; Peiris JS; Yuen KY J Clin Virol; 2004 Sep; 31(1):69-75. PubMed ID: 15288617 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin has a potent antiviral activity against SARS coronavirus. Amici C; Di Caro A; Ciucci A; Chiappa L; Castilletti C; Martella V; Decaro N; Buonavoglia C; Capobianchi MR; Santoro MG Antivir Ther; 2006; 11(8):1021-30. PubMed ID: 17302372 [TBL] [Abstract][Full Text] [Related]
10. Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virus. Subramanian GM; Moore PA; Gowen BB; Olsen AL; Barnard DL; Paragas J; Hogan RJ; Sidwell RW Chemotherapy; 2008; 54(3):176-80. PubMed ID: 18560223 [TBL] [Abstract][Full Text] [Related]
11. Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. He R; Adonov A; Traykova-Adonova M; Cao J; Cutts T; Grudesky E; Deschambaul Y; Berry J; Drebot M; Li X Biochem Biophys Res Commun; 2004 Aug; 320(4):1199-203. PubMed ID: 15249217 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Barnard DL; Day CW; Bailey K; Heiner M; Montgomery R; Lauridsen L; Chan PK; Sidwell RW Antivir Chem Chemother; 2006; 17(5):275-84. PubMed ID: 17176632 [TBL] [Abstract][Full Text] [Related]
13. Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. Morgenstern B; Michaelis M; Baer PC; Doerr HW; Cinatl J Biochem Biophys Res Commun; 2005 Jan; 326(4):905-8. PubMed ID: 15607755 [TBL] [Abstract][Full Text] [Related]
14. [Anti-SARS virus activities of different recombinant human interferons in cell culture system]. Duan ZJ; Zhang LL; Xie ZP; Yu ZA; Zhang LP; Zhang B; Liu YQ; Wang JW; Li WP; Zhang CH; Ma XJ; Shu YL; Duan SM; Li DX; Hou YD Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):205-8. PubMed ID: 15340558 [TBL] [Abstract][Full Text] [Related]
15. Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus. Yang CW; Lee YZ; Kang IJ; Barnard DL; Jan JT; Lin D; Huang CW; Yeh TK; Chao YS; Lee SJ Antiviral Res; 2010 Nov; 88(2):160-8. PubMed ID: 20727913 [TBL] [Abstract][Full Text] [Related]
16. [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome]. Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP Antibiot Khimioter; 2011; 56(9-10):41-6. PubMed ID: 22586904 [TBL] [Abstract][Full Text] [Related]
17. The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. Spiegel M; Pichlmair A; Mühlberger E; Haller O; Weber F J Clin Virol; 2004 Jul; 30(3):211-3. PubMed ID: 15135736 [TBL] [Abstract][Full Text] [Related]
18. [Preventive and therapeutic effects of recombinant IFN-alpha2b nasal spray on SARS-CoV infection in Macaca mulata]. Gao H; Zhang LL; Wei Q; Duan ZJ; Tu XM; Yu ZA; Deng W; Zhang LP; Bao LL; Zhang B; Tong W; Hou YD; Zhang BL; Huang L; Qin C Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):207-10. PubMed ID: 16261198 [TBL] [Abstract][Full Text] [Related]
19. Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers. Neuman BW; Stein DA; Kroeker AD; Churchill MJ; Kim AM; Kuhn P; Dawson P; Moulton HM; Bestwick RK; Iversen PL; Buchmeier MJ J Virol; 2005 Aug; 79(15):9665-76. PubMed ID: 16014928 [TBL] [Abstract][Full Text] [Related]
20. Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. Paragas J; Blatt LM; Hartmann C; Huggins JW; Endy TP Antiviral Res; 2005 Jun; 66(2-3):99-102. PubMed ID: 15911026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]